Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity

Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity

IntroductionTNFα inhibitor (TNFi) immunogenicity in rheumatoid arthritis (RA) is a major obstacle to its therapeutic effectiveness. Although methotrexate (MTX) can mitigate TNFi immunogenicity, its adverse effects necessitate alternative strategies. Targeting nuclear factor of activated T cells (NFA...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aboli Bhingarkar, Yuyin Wang, Keito Hoshitsuki, Katherine Marie Eichinger, Sanjay Rathod, Yin Zhu, He Lyu, Andrew T. McNutt, Larry W. Moreland, Lee McDermott, David R. Koes, Christian A. Fernandez
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	rheumatoid arthritis antidrug antibodies (ADA) NFAT (nuclear factor of activated T cells) methotrexate adalimumab duvelisib
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1397995/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adalimumab-induced optic neuropathy in a patient with Behçet’s syndrome
by: Sofia Miranda, et al.
Published: (2025-01-01)

Tuberculosis of the tongue in a patient under treatment with adalimumab
by: Cintia Mussi Milani, et al.
Published: (2024-12-01)

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
by: Edyta Szymanska, et al.
Published: (2016-12-01)

Successful treatment of pyoderma gangrenosum complicated by JAK2V617F mutation-positive myelofibrosis with adalimumab and systemic steroid
by: Kyohei Shibuta, et al.
Published: (2025-01-01)

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center
by: Roxana Matran, et al.
Published: (2025-01-01)

Successful Treatment of Annular Atrophic Lichen Planus With Adalimumab
by: Joe Khodeir, et al.
Published: (2025-01-01)

Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01)

Approaches and outcomes of adalimumab discontinuation in patients with well-controlled inflammatory arthritis: a systematic search and review
by: Erin Balay-Dustrude, et al.
Published: (2024-12-01)

Size exclusion chromatography as green support for forced degradation study of adalimumab
by: Kovačić Jelena, et al.
Published: (2023-12-01)

Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation
by: Chunbo Zhang, et al.
Published: (2025-01-01)

The Efficacy of Adalimumab Treatment in Pediatric Non-Infectious Uveitis: A Retrospective Cohort Study
by: Kübra Özdemir Yalçınsoy, et al.
Published: (2024-12-01)

Adalimumab induced psoriasis in Crohn’s disease and treatment with ustekinumab: case report and special histopathological findings
by: Fang Qiu, et al.
Published: (2025-01-01)

Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs
by: Anna Pau, et al.
Published: (2025-01-01)

Efficacy of adalimumab for Hailey-Hailey disease demonstrated by reduction of the Pemphigus Disease Area Index
by: Madeleine Stark, MChD, et al.
Published: (2025-02-01)

Case report: dysgeusia, strawberry tongue, and psoriatic eruptions after combination treatment with adalimumab, sulfasalazine, and etoricoxib for ankylosing spondylitis
by: Binglin Cui, et al.
Published: (2025-02-01)

Biosimilars in Focus: Evaluating Their Role Compared to Adalimumab in Clinical Practice
by: Dorota Waz, et al.
Published: (2025-01-01)

Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells
by: Dana Emerson, et al.
Published: (2025-02-01)

Dual immunomodulator therapy with adalimumab and upadacitinib to treat recalcitrant hidradenitis suppurativa
by: Zahidul Islam, BA, et al.
Published: (2025-02-01)

Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience
by: Marcin Sochal, et al.
Published: (2019-12-01)

Therapeutic drug monitoring and neutralizing anti-drug antibody detection to optimize TNF-alpha inhibitor treatment for uveitis
by: Howard C. Chen, et al.
Published: (2025-01-01)

Potential Role of Gene Regulator NFAT5 in the Pathogenesis of Diabetes Mellitus
by: Lusha Cen, et al.
Published: (2020-01-01)

Inflammatory Bowel Diseases in Children: Modern Achievements in Diagnostics and Therapy
by: A. I. Khavkin, et al.
Published: (2024-01-01)

NFAT5 Contributes to Osmolality-Induced MCP-1 Expression in Mesothelial Cells
by: Christoph Küper, et al.
Published: (2012-01-01)

In Vivo Exposure of Deltamethrin Dysregulates the NFAT Signalling Pathway and Induces Lung Damage
by: Prakriti Sharma, et al.
Published: (2024-01-01)

Staphylococcal Toxic Shock Syndrome Caused by Tampon Use
by: Cian McDermott, et al.
Published: (2015-01-01)

UNDERSTANDING COMPLEXITY WITHIN ENERGY INFRASTRUCTURE DELIVERY SYSTEMS IN DEVELOPING COUNTRIES: ADOPTING A VIABLE SYSTEMS APPROACH
by: B.O. Awuzie, et al.
Published: (2013-05-01)

NFAT and AP1 are Essential for the Expression of a Glioblastoma Multiforme Related IL-13Ra2 Transcript
by: Anhua Wu, et al.
Published: (2010-01-01)

The Readability of Patient Education Materials Pertaining to Gastrointestinal Procedures
by: Mohammad S. Nawaz, et al.
Published: (2021-01-01)

The Social Meanings of Artifacts: Face Masks in the COVID-19 Pandemic
by: Franziska Schönweitz, et al.
Published: (2022-04-01)

The Value of a Hole in Coal: Assessment of Seasonal Thermal Energy Storage and Recovery in Flooded Coal Mines
by: Jesus Perez Silva, et al.
Published: (2022-12-01)

Design for green lean six sigma to improve sustainability in the pharmaceutical industry – a case study
by: Yvonne McGlinchey, et al.
Published: (2025-12-01)

Effects of Rainfall on E. coli Concentrations at Door County, Wisconsin Beaches
by: Gregory T. Kleinheinz, et al.
Published: (2009-01-01)

Stroke in the Setting of Giant Cell Arteritis: A Case Report
by: S. McDermott, et al.
Published: (2010-01-01)

Data-driven model discovery and model selection for noisy biological systems.
by: Xiaojun Wu, et al.
Published: (2025-01-01)

Emergency Caesarean Section: Influences on the Decision-to-Delivery Interval
by: Aiste Cerbinskaite, et al.
Published: (2011-01-01)

Planetary health education in undergraduate medical education in Germany: results from structured interviews and an online survey within the national PlanetMedEd Project
by: Fabio Grieco, et al.
Published: (2025-02-01)

Which patients received a ReSPECT form, what was documented and what were the patient outcomes? A protocol for a retrospective observational study investigating the impact of the COVID-19 pandemic on the implementation of the ReSPECT process
by: Lucy Selman, et al.
Published: (2022-07-01)

The power of social capital: the significance of relationships in third space practice
by: Diane Nutt, et al.
Published: (2025-01-01)

Colonial breeding impacts potentially fitness-relevant cognitive processes in barn swallows
by: Angela Medina-García, et al.
Published: (2024-03-01)

Travailler peut nuire gravement à votre santé d’Annie Thébaud-Mony
by: Katherine Lippel, et al.
Published: (2008-11-01)